Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines (2022)

Chapter: Appendix C: Agendas: Open Committee Meetings

Previous Chapter: Appendix B: Biographical Sketches of Committee Members and Staff
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.

Appendix C

Agendas: Open Committee Meetings

This appendix presents the agendas for the open portions of the committee’s meetings, at which a wide range of experts provided invaluable input to the committee’s deliberations.

Committee on Addressing Issues of Vaccine Distribution and Supply
Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

March Meeting
March 11, 2021: 12:00 pm ET – 1:30 pm ET
March 12, 2021: 11:00 am ET – 12:30 pm ET
March 17, 2021: 10:45 am – 1:15 pm ET
March 19, 2021: 11:00 am – 12:15 pm ET
Location: Virtual

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.

Wednesday, March 17, 2021

OPEN SESSION

SESSION II

SPONSOR BRIEFING: DISCUSSION OF THE COMMITTEE’S CHARGE

10:45 a.m. Welcome and Introductions

RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and

Management Chair

President’s Advisory Committee on Labor

Standards and Human Rights

University of Michigan

10:55 a.m.

Sponsor Perspective on Charge to the Committee

LAWRENCE KERR, Sponsor

Office of Pandemic and Emerging Threats

Office of Global Affairs

U.S. Department of Health and Human Services

11:10 a.m.

Q&A Discussion with Committee

11:25 a.m. BREAK
SESSION III

PANDEMIC INFLUENZA AND NEW PATHOGEN VACCINE DISTRIBUTION

11:35 a.m.

Needs in Influenza and New Pathogen Vaccine Distribution

LISA HEDMAN

Group Lead, Supply and Access to Medicines

World Health Organization

NAGWA HASANIN

Senior Advisor, Health

UNICEF

STACEY KNOBLER

Director, Influenza Vaccine Innovation

Sabin Vaccine Institute

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.

Session Moderator

PINAR KESKINOCAK

William W. George Professor and Chair

School of Industrial and Systems Engineering

Georgia Institute of Technology

1:00 p.m.

Q&A Discussion with Committee

1:15 p.m. ADJOURN

Friday, March 19, 2021

OPEN SESSION

SESSION IV

NEEDS IN INFLUENZA VACCINE MANUFACTURING PREPAREDNESS

11:00 a.m.

Welcome and Recap of Day 1

11:10 a.m. Needs in Influenza Vaccine Manufacturing Preparedness
RICK BRIGHT

Senior Vice-President, Pandemic Preparedness

The Rockefeller Foundation

MATTHEW DOWNHAM

Sustainable Manufacturing Lead

Coalition for Epidemic Preparedness Innovations (CEPI)

TIAGO ROCCA

Strategic Partnerships and Business Development Manager

Butantan Institute

Session Moderator

JENNIFER PANCORBO

Director, Industry Programs and Research

North Carolina State University

Biomanufacturing Training and Education Center

11:55 a.m. Q&A Discussion with Committee
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
12:15 p.m. ADJOURN OPEN SESSION

April Meeting
April 23, 2021: 9:30 am ET – 12:00 pm ET
April 27, 2021: 11:30 am ET – 12:30 pm ET
April 30, 2021: Closed Session for Committee Members Only
Location: Virtual

Friday, April 23, 2021

OPEN SESSION

9:30 a.m. Welcome

RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair

President’s Advisory Committee on Labor Standards and Human Rights

University of Michigan

SESSION I CRITICAL INPUTS FOR VACCINE MANUFACTURING

Speakers will share their perspective on the critical inputs necessary for vaccine manufacturing.

9:35 a.m. ROBERT JOHNSON

Director, Influenza and Emerging Infectious Diseases Division

Biomedical Advanced Research and Development Authority

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
MICHAEL ANGELASTRO

Lead Interdisciplinary Scientist

Biomedical Advanced Research and Development Authority

9:50 a.m.

Q&A Discussion with Committee

10:05 a.m. SAI PRASAD

President of Quality Operations, Bharat

Biotech International Ltd.

10:20 a.m.

Q&A Discussion with Committee

10:35 a.m. WILLIAM JAY TREAT

Chief Manufacturing Officer and Principal Investigator

Center for Innovation in Advanced Development & Manufacturing Texas A&M University

10:50 a.m. Q&A Discussion with Committee Moderator
MATTHEW DOWNHAM

Sustainable Manufacturing Lead

Coalition for Epidemic Preparedness Innovations

11:05 a.m. BREAK

SESSION II NOVEL TECHNOLOGIES FOR INFLUENZA VACCINE MANUFACTURING

Speakers will discuss how novel technologies and advances in translational research and science, derived from the ongoing COVID-19 pandemic, have the potential to be adapted to scale-up and sustain influenza vaccine manufacturing capacities.

11:10 a.m. Technology Scale-Up and Adaptability
LYN MORGAN

Senior Director Global Public Affairs, Vaccines

Sanofi Pasteur

SURESH JADHAV

Executive Director

Serum Institute of India

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
PATRICK TIPPOO

Head of Science and Innovation

Biovac Institute

Moderator
RICK BRIGHT

Senior Vice-President, Pandemic Preparedness

The Rockefeller Foundation

11:40 a.m. Q&A Discussion with Committee
12:00 p.m. ADJOURN

Tuesday, April 27, 2021

OPEN SESSION

11:30 a.m. Welcome and Recap of Day 1
RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management

Chair, President’s Advisory Committee on Labor Standards and Human Rights

University of Michigan

11:35 a.m. Key Considerations for Vaccine Distribution
PINAR KESKINOCAK

William W. George Professor and Chair

School of Industrial and Systems Engineering

Georgia Institute of Technology

11:50 a.m. Q&A Discussion with Committee
12:00 p.m. Vaccine Information Systems: Improvements Needed to Support Influenza
SKYE GILBERT

Executive Director, Digital Square

PATH

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
12:15 p.m. Q&A Discussion with Committee Moderator
PRASHANT YADAV, Committee Vice Chair

Senior Fellow, Center for Global Development

Professor, INSEAD

Lecturer, Harvard Medical School

12:30 p.m. ADJOURN OPEN SESSION

May Meeting
May 21, 2021: 11:25 am ET – 1:30 pm ET
Location: Virtual

Friday, May 21, 2021

OPEN SESSION

11:25 a.m. Welcome & Recap of Day 2
RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management Chair

President’s Advisory Committee on Labor Standards and Human Rights

University of Michigan

11:30 a.m. Cross-Border Processes and Approval for Vaccines and Vaccine Supplies
ROY SANTANA

Counsellor

Market Access Division

World Trade Organization

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
MICHAEL ROBERTS

Head, Aid for Trade Unit

Development Division

World Trade Organization

ROGER KAMPF

Counsellor

Intellectual Property Division

World Trade Organization

11:45 a.m. Q&A Discussion with Committee
Moderator
MATTHEW DOWNHAM

Sustainable Manufacturing Lead

Coalition for Epidemic Preparedness Innovations

12:00 p.m. Pandemic Influenza Vaccine Distribution: The PIVI Model
JOSEPH BRESEE

Associate Director of Global Health Affairs, Influenza Division

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention

Director, Partnership for Influenza Vaccine Introduction Task Force for Global Health

Director, Global Funders Consortium for Universal Influenza Vaccine Development

12:15 p.m. Q&A Discussion with Committee Moderator
RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management

Chair, President’s Advisory Committee on Labor Standards and Human Rights

University of Michigan

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
12:30 p.m. WHO Training Programs and mRNA Hubs
MARTIN FRIEDE

Coordinator

Initiative for Vaccine Research

World Health Organization

12:45 p.m. Q&A Discussion with Committee Moderator
JENNIFER PANCORBO

Director, Industry Programs and Research

Biomanufacturing Training and Education Center

North Carolina State University

1:00 p.m. Navigating Vaccine Logistics in Africa
AHMED OGWELL OUMA

Deputy Director

Africa Centres for Disease Control and Prevention

1:15 p.m. Q&A Discussion with Committee Moderator
RAVI ANUPINDI, Committee Chair

Colonel William G. and Ann C. Svetlich Professor of Operations Research and Management

Chair, President’s Advisory Committee on Labor Standards and Human Rights

University of Michigan

1:30 p.m. ADJOURN OPEN SESSION
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.

This page intentionally left blank.

Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 231
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 232
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 233
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 234
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 235
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 236
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 237
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 238
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 239
Suggested Citation: "Appendix C: Agendas: Open Committee Meetings." National Academies of Sciences, Engineering, and Medicine and National Academy of Medicine. 2022. Globally Resilient Supply Chains for Seasonal and Pandemic Influenza Vaccines. Washington, DC: The National Academies Press. doi: 10.17226/26285.
Page 240
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.